BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salomaa S, Bouffler SD, Atkinson MJ, Cardis E, Hamada N. Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia? International Journal of Radiation Biology 2020;96:1228-35. [DOI: 10.1080/09553002.2020.1786609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Piras A, Venuti V, D’aviero A, Cusumano D, Pergolizzi S, Daidone A, Boldrini L. Covid-19 and radiotherapy: a systematic review after 2 years of pandemic. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00513-9] [Reference Citation Analysis]
2 Kilicoglu O, Kara U, Ozgenc E, Gundogdu E. Pre-clinic study of radiopharmaceutical for Covid-19 inactivation: Dose distribution with Monte Carlo Simulation. Appl Radiat Isot 2022;188:110364. [PMID: 35839712 DOI: 10.1016/j.apradiso.2022.110364] [Reference Citation Analysis]
3 Little MP, Zhang W, van Dusen R, Hamada N, Bugden M, Cao M, Thomas K, Li D, Wang Y, Chandrashekhar M, Khan MK, Coleman CN. Low-dose radiotherapy for COVID-19 pneumonia and cancer: summary of a recent symposium and future perspectives. Int J Radiat Biol 2022;:1-43. [PMID: 35511152 DOI: 10.1080/09553002.2022.2074165] [Reference Citation Analysis]
4 Dawood A, Mothersill C, Seymour C. Low dose ionizing radiation and the immune response: what is the role of non-targeted effects? Int J Radiat Biol 2021;:1-15. [PMID: 34330196 DOI: 10.1080/09553002.2021.1962572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Hollingsworth BA, Cassatt DR, DiCarlo AL, Rios CI, Satyamitra MM, Winters TA, Taliaferro LP. Acute Radiation Syndrome and the Microbiome: Impact and Review. Front Pharmacol 2021;12:643283. [PMID: 34084131 DOI: 10.3389/fphar.2021.643283] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
6 Miran C, Bonnet É, Allignet B, Clippe S, El Hedi Zouai M, Bosset M, Fleury B, Guy JB. [Low dose radiotherapy for COVID-19 pneumopathy: Biological rationale and literature review]. Cancer Radiother 2021;25:494-501. [PMID: 33903009 DOI: 10.1016/j.canrad.2021.03.005] [Reference Citation Analysis]
7 Pallares RM, Abergel RJ. Diagnostic, Prognostic, and Therapeutic Use of Radiopharmaceuticals in the Context of SARS-CoV-2. ACS Pharmacol Transl Sci 2021;4:1-7. [PMID: 33615159 DOI: 10.1021/acsptsci.0c00186] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Neumaier F, Zlatopolskiy BD, Neumaier B. Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics. Pharmaceutics 2020;12:E1247. [PMID: 33371500 DOI: 10.3390/pharmaceutics12121247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Arruda GV, Weber RRDS, Bruno AC, Pavoni JF. The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case. Int J Radiat Biol 2021;97:120-5. [PMID: 33164596 DOI: 10.1080/09553002.2021.1846818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
10 Little MP, Zhang W, van Dusen R, Hamada N. Pneumonia After Bacterial or Viral Infection Preceded or Followed by Radiation Exposure: A Reanalysis of Older Radiobiologic Data and Implications for Low-Dose Radiation Therapy for Coronavirus Disease 2019 Pneumonia. Int J Radiat Oncol Biol Phys 2021;109:849-58. [PMID: 33011212 DOI: 10.1016/j.ijrobp.2020.09.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hertzog RG, Bicheru SN. Radiotherapy in the fight against pneumonia associated with SARS-CoV-2. Int J Radiat Biol 2020;96:1319-22. [PMID: 32931359 DOI: 10.1080/09553002.2020.1822560] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 [DOI: 10.1101/2020.05.11.077651] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]